Stock Z1BH34 ZIMMER BIOMET HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Zimmer Biomet Holdings, Inc. Sao Paulo

Equities

Z1BH34

BRZ1BHBDR007

Market Closed - Sao Paulo
Other stock markets
 15:36:12 2024-02-21 EST 		5-day change 1st Jan Change
158.2 BRL +4.66% Intraday chart for Zimmer Biomet Holdings, Inc. -.--% -8.10%
06-20 Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors CI
06-12 Zimmer Biomet Enters Co-Marketing Deal With RevelAi Health MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zimmer Biomet Holdings Insider Sold Shares Worth $1,474,582, According to a Recent SEC Filing
MT
Barclays Adjusts Price Target on Zimmer Biomet to $125 From $130
MT
Barclays Adjusts Price Target on Zimmer Biomet Holdings to $125 From $130
MT
Argus Upgrades Zimmer Biomet to Buy From Hold With $150 Price Target
MT
Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142
MT
UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating
MT
Truist Adjusts Zimmer Biomet Holdings' PT to $130 From $137, Keeps Hold Rating
MT
Bernstein Adjusts Price Target on Zimmer Biomet to $133 From $132
MT
Jefferies Adjusts Price Target on Zimmer Biomet to $135 From $136
MT
Citigroup Adjusts Price Target on Zimmer Biomet to $134 From $140
MT
Morgan Stanley Adjusts Price Target on Zimmer Biomet to $130 From $135
MT
Jefferies Adjusts Zimmer Biomet Price Target to $135 From $136
MT
Citigroup Adjusts Zimmer Biomet Price Target to $134 From $140
MT
Morgan Stanley Adjusts Zimmer Biomet Price Target to $130 From $135
MT
Oppenheimer Adjusts Price Target on Zimmer Biomet Holdings to $155 From $150
MT
BTIG Adjusts Price Target on Zimmer Biomet to $139 From $138, Keeps Buy Rating
MT
Truist Securities Adjusts Zimmer Biomet Price Target to $137 From $135, Hold Rating Kept
MT
Citigroup Raises Price Target on Zimmer Biomet to $140 From $134, Keeps Neutral Rating
MT
UBS Adjusts Zimmer Biomet Price Target to $109 From $105, Maintains Sell Rating
MT
Deutsche Bank Adjusts Zimmer Biomet Price Target to $140 From $147, Maintains Hold Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZBH Stock
  4. Z1BH34 Stock
  5. News Zimmer Biomet Holdings, Inc.
  6. Analyst Reco.